The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes
Abstract
INTRODUCTION: Artificial intelligence (AI) is changing the field of nanomedicine by exploring novel nanomaterials for developing therapies of high efficacy. AI works on larger datasets, finding sought-after nano-properties for different therapeutic aims and eventually enhancing nanomaterials' safety and effectiveness. AI leverages patient clinical and genetic data to predict outcomes, guide treatments, and optimize drug dosages and forms, enhancing benefits while minimizing side effects. AI-supported nanomedicine faces challenges like data fusion, ethics, and regulation, requiring better tools and interdisciplinary collaboration. This review highlights the importance of AI regarding patient care and urges scientists, medical professionals, and regulators to adopt AI for better outcomes. AREAS COVERED: Personalized Nanomedicine, Material Discovery, AI-Driven Therapeutics, Data Integration, Drug Delivery, Patient Centric Care. EXPERT OPINION: Today, AI can improve personalized health wellness through the discovery of new types of drug nanocarriers, nanomedicine of specific properties to tackle targeted medical needs, and an increment in efficacy along with safety. Nevertheless, problems such as ethical issues, data security, or unbalanced data sets need to be addressed. Potential future developments involve using AI and quantum computing together and exploring telemedicine i.e. the Internet-of-Medical-Things (IoMT) approach can enhance the quality of patient care in a personalized manner by timely decision-making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Wearable biosensors for healthcare monitoring
Kim, J., Campbell, A. S., de Ávila, B. E.-F., & Wang, J. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0045-y · Cited by 3,373
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., Aldairem, A., Alrashed, M., Bin Saleh, K., Badreldin, H. A., et al. (2023) · BMC Medical Education · doi:10.1186/s12909-023-04698-z · Cited by 3,146 · cited 1×
“These tools allow healthcare providers to real-time data collection, continuous patient monitoring, and the development of customized treatment strategies tailored to individual patient needs [129–133].”
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · cited 2×
“In the realm of personalized nanomedicine, AI speeds up the search for novel nanomaterials but also fine-tunes their design for specific medical purposes, creating more effective and personalized treatment options [37,50,51].”
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Precision medicine, AI, and the future of personalized health care
Johnson, K. B., Wei, W., Weeraratne, D., Frisse, M. E., Misulis, K., Rhee, K., Zhao, J., & Snowdon, J. L. (2021) · Clinical and Translational Science · doi:10.1111/cts.12884 · Cited by 1,854 · cited 3×
“All things considered, in 2020s the combination of nanomedicine and AI/ML has revolutionized personalized medicine, and prospects for the future are growing to include telemedicine, genomic-based therapies, and other developments in precision healthcare [20].”
Telemedicine for Healthcare: Capabilities, Features, Barriers, and Applications
Haleem, A., Javaid, M., Singh, R. P., & Suman, R. (2021) · Sensors International · doi:10.1016/j.sintl.2021.100117 · Cited by 1,638
Materials discovery and design using machine learning
Liu, Y., Zhao, T., Ju, W., & Shi, S. (2017) · Journal of Materiomics · doi:10.1016/j.jmat.2017.08.002 · Cited by 1,276
Recent advances and applications of deep learning methods in materials science
Choudhary, K., DeCost, B., Chen, C., Jain, A., Tavazza, F., Cohn, R., Park, C. W., Choudhary, A., Agrawal, A., Billinge, S. J. L., et al. (2022) · npj Computational Materials · doi:10.1038/s41524-022-00734-6 · Cited by 1,172 · cited 2×
“Emerging DL applications in spectroscopic data analysis are discussed in Figure 4(b) [94].”
Toward Scalable Systems for Big Data Analytics: A Technology Tutorial
Hu, H., Wen, Y., Chua, T.-S., & Li, X. (2014) · IEEE Access · doi:10.1109/access.2014.2332453 · Cited by 1,099
Cited by
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Wang, K., Yang, R., Li, J., Wang, H., Wan, L., & He, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591438 · Cited by 27
El-khawaga, A. M., Youssef, O. I., El-dydamoni, O. A., Ragab, W. M., & Mohammed, R. A. E. (2026) · European Journal of Medical Research · doi:10.1186/s40001-025-03804-9 · Cited by 14
“This targeted approach will maximize delivery and minimize side effects [105, 106].”
Metadata
- Authors
- Mazumdar, H., Khondakar, K. R., Das, S., Halder, A., & Kaushik, A.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2024-12-15
- Volume
- 22
- Issue
- 1
- Pages
- 85-108
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W4405152527
- Cited by
- 159
- References
- 29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes. https://app.cochat.ai/papers/10.1080/17425247.2024.2440618
- The paper
- Mazumdar, H., Khondakar, K. R., Das, S., Halder, A., & Kaushik, A. (2025). Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes. Expert Opinion on Drug Delivery. https://doi.org/10.1080/17425247.2024.2440618
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.